Image may be NSFW.
Clik here to view.
Clik here to view.
Mati Therapeutics isn’t your traditional biotech startup
Not quite two years old yet, closely held Mati Therapeutics is conducting a pre-Phase 3 clinical trial with an ocular punctal plug delivery system (PPDS) that could become a preferred alternative to...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
EyeGate developing non-invasive ophthalmic treatments
EyeGate Pharmaceuticals (NASDAQ:EYEG) is developing a non-invasive drug delivery platform that uses an electrical process, known as iontophoresis, to deliver a corticosteroid to the front-and...
View Article
More Pages to Explore .....
